INKT
MiNK Therapeutics, Inc.Company with tickers: INKT
CIK
1840229
CUSIP
603693201
Shares Outstanding
4,981,899
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $1,204,090 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Operating Income | $-2,881,787 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Net Income | $-2,742,368 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Basic) | $-0.57 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Diluted) | $-0.57 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |